NCT06584461View on ClinicalTrials.gov

Interest of Lidocaine in Children with Upper Airway Infection Undergoing General Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

February 5, 2024

Conditions
Upper Respiratory Tract InfectionsPerioperative Respiratory Complications
Interventions
DRUG

Lidocaine (drug)

IV lidocaine, administered once during the induction of anesthesia.

DRUG

Saline (NaCl 0,9 %) (placebo)

IV placebo (normal saline), administered once during the induction of anesthesia.

Trial Locations (1)

1029

Bechir Hamza Children's Hospital, Tunis

All Listed Sponsors
lead

Tunis University

OTHER